A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer
JJ Miller, C Gaiddon, T Storr - Chemical Society Reviews, 2020 - pubs.rsc.org
Referred to as the “guardian of the genome”, p53 is the most frequently mutated protein in
cancer and almost all cancers exhibit malfunction along the p53 pathway. As an …
cancer and almost all cancers exhibit malfunction along the p53 pathway. As an …
[引用][C] A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer
J Miller, C Gaiddon, T Storr - Chemical Society Reviews, 2020 - inria.hal.science
A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer
- Inria - Institut national de recherche en sciences et technologies du numérique Accéder …
- Inria - Institut national de recherche en sciences et technologies du numérique Accéder …
A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer.
JJ Miller, C Gaiddon, T Storr - Chemical Society Reviews, 2020 - europepmc.org
Referred to as the" guardian of the genome", p53 is the most frequently mutated protein in
cancer and almost all cancers exhibit malfunction along the p53 pathway. As an …
cancer and almost all cancers exhibit malfunction along the p53 pathway. As an …
A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer
JJ Miller, C Gaiddon, T Storr - Chemical Society reviews, 2020 - pubmed.ncbi.nlm.nih.gov
Referred to as the" guardian of the genome", p53 is the most frequently mutated protein in
cancer and almost all cancers exhibit malfunction along the p53 pathway. As an …
cancer and almost all cancers exhibit malfunction along the p53 pathway. As an …